12-96247396-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005230.4(ELK3):āc.664A>Gā(p.Ile222Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005230.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELK3 | NM_005230.4 | c.664A>G | p.Ile222Val | missense_variant | 3/5 | ENST00000228741.8 | NP_005221.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELK3 | ENST00000228741.8 | c.664A>G | p.Ile222Val | missense_variant | 3/5 | 1 | NM_005230.4 | ENSP00000228741 | P1 | |
ELK3 | ENST00000552142.5 | c.208-12335A>G | intron_variant | 5 | ENSP00000449430 | |||||
ELK3 | ENST00000549985.1 | c.153+113A>G | intron_variant, NMD_transcript_variant | 3 | ENSP00000449420 |
Frequencies
GnomAD3 genomes AF: 0.000290 AC: 44AN: 151834Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251238Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135822
GnomAD4 exome AF: 0.0000322 AC: 47AN: 1461820Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727208
GnomAD4 genome AF: 0.000290 AC: 44AN: 151952Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74262
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | The c.664A>G (p.I222V) alteration is located in exon 3 (coding exon 2) of the ELK3 gene. This alteration results from a A to G substitution at nucleotide position 664, causing the isoleucine (I) at amino acid position 222 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at